Fibrin, a scaffold material for islet transplantation and pancreatic endocrine tissue engineering

Tissue Engineering - Part B: Reviews

Volumn 21, Issue 1, 2015, Pages 34-44

  Riopel, Matthew ^a,b   Trinder, Mark ^a,b   Wang, Rennian ^a,b  

^a CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CELL DEATH; CELL MEMBRANES;

BIODEGRADABLE SCAFFOLD; CELL BASED THERAPIES; CELL DIFFERENTIATION; CELL SURFACE RECEPTORS; ISLET TRANSPLANTATION; NEO-VASCULARIZATION; PROTECTIVE EFFECTS; SCAFFOLD MATERIALS;

SCAFFOLDS (BIOLOGY);

ARGINYLGLYCYLASPARTIC ACID; CELL SURFACE RECEPTOR; FIBRIN; INTEGRIN RECEPTOR; BIOMATERIAL;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CELL TRANSPLANTATION; CYTOARCHITECTURE; DIABETES MELLITUS; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INSULIN RELEASE; MOUSE; MYOFIBROBLAST; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN MOTIF; SEALANT; TISSUE ENGINEERING; TISSUE SCAFFOLD; VASCULARIZATION; WOUND HEALING; ANIMAL; CHEMISTRY; DRUG EFFECTS; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; FIBRIN; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84922696908     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2014.0188     Document Type: Article

References (146)

1. Baum, C.L., and Arpey, C.J. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31, 674, 2005.
2. Weisel, J.W., Nagaswami, C., and Makowski, L. Twisting of fibrin fibers limits their radial growth. Proc Natl Acad Sci U S A 84, 8991, 1987.
3. Mosesson, M.W. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3, 1894, 2005.
4. Yang, W., Wu, B., Asakura, S., Kohno, I., and Matsuda, M. Soluble fibrin augments spreading of fibroblasts by providing RGD sequences of fibrinogen in soluble fibrin. Thromb Res 114, 293, 2004.
5. Tennent, G.A., Brennan, S.O., Stangou, A.J., O'Grady, J., Hawkins, P.N., and Pepys, M.B. Human plasma fibrinogen is synthesized in the liver. Blood 109, 1971, 2007.
6. Adams, R.L., and Bird, R.J. Review article: coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton) 14, 462, 2009.
7. Blomback, B., Hessel, B., Hogg, D., and Therkildsen, L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature 275, 501, 1978.
8. Muller, M.F., Ris, H., and Ferry, J.D. Electron microscopy of fine fibrin clots and fine and coarse fibrin films. Observations of fibers in cross-section and in deformed states. J Mol Biol 174, 369, 1984.
9. Torbet, J., Freyssinet, J.M., and Hudry-Clergeon, G. Oriented fibrin gels formed by polymerization in strong magnetic fields. Nature 289, 91, 1981.
10. Weisel, J., and Litvinov, R. Mechanisms of fibrin polymerization and clinical implications. Blood 121, 1712, 2013.
11. Fogelson, A., and Keener, J. Toward an understanding of fibrin branching structure. Phys Rev E Stat Nonlin Soft Matter Phys 81, 51922, 2010.
12. Bensaid, W., Triffitt, J.T., Blanchat, C., Oudina, K., Sedel, L., and Petite, H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24, 2497, 2003.
13. Uitte de Willige, S., Standeven, K.F., Philippou, H., and Ariens, R.A. The pleiotropic role of the fibrinogen gamma' chain in hemostasis. Blood 114, 3994, 2009.
14. Weisel, J.W. Which knobs fit into which holes in fibrin polymerization? J Thromb Haemost 5, 2340, 2007.
15. Janmey, P., Winer, J., and Weisel, J. Fibrin gels and their clinical and bioengineering applications. J R Soc Interface 6, 1, 2009.
16. Jorneskog, G., Egberg, N., Fagrell, B., Fatah, K., Hessel, B., Johnsson, H., et al. Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia 39, 1519, 1996.
17. Undas, A., Topor-Madry, R., Tracz, W., and Pasowicz, M. Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis. Thromb Haemost 102, 1289, 2009.
18. Undas, A., Brozek, J., Jankowski, M., Siudak, Z., Szczeklik, A., and Jakubowski, H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler Thromb Vasc Biol 26, 1397, 2006.
19. Wilhelmsen, L., Svardsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., and Tibblin, G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311, 501, 1984.
20. Machlus, K.R., Cardenas, J.C., Church, F.C., and Wolberg, A.S. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 117, 4953, 2011.
21. Kerlin, B., Cooley, B., Isermann, B., Hernandez, I., Sood, R., Zogg, M., et al. Cause-effect relation between hyperfibrinogenemia and vascular disease. Blood 103, 1728, 2004.
22. Kim, S.H., Turnbull, J., and Guimond, S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 209, 139, 2011.
23. Arnaout, M.A., Mahalingam, B., and Xiong, J.P. Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol 21, 381, 2005.
24. Hynes, R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673, 2002.
25. Barczyk, M., Carracedo, S., and Gullberg, D. Integrins. Cell Tissue Res 339, 269, 2010.
26. Desgrosellier, J.S., and Cheresh, D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10, 9, 2010.
27. Somanath, P.R., Malinin, N.L., and Byzova, T.V. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis 12, 177, 2009.
28. Yokoyama, K., Zhang, X.P., Medved, L., and Takada, Y. Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains. Biochemistry 38, 5872, 1999.
29. Bayless, K.J., Salazar, R., and Davis, G.E. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am J Pathol 156, 1673, 2000.
30. Vailhé, B., Ronot, X., Tracqui, P., Usson, Y., and Tranqui, L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to avb3 integrin localization. In Vitro Cell Dev Biol Anim 33, 763, 1997.
31. Xu, Q., Chen, X., Fu, B., Ye, Y., Yu, L., Wang, J., et al. Integrin alphavbeta3-RGDS interaction mediates fibrininduced morphological changes of glomerular endothelial cells. Kidney Int 56, 1413, 1999.
32. Gailit, J., Clarke, C., Newman, D., Tonnesen, M.G., Mosesson, M.W., and Clark, R.A. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha (v)beta3. Exp Cell Res 232, 118, 1997.
33. Katagiri, Y., Hiroyama, T., Akamatsu, N., Suzuki, H., Yamazaki, H., and Tanoue, K. Involvement of alpha v beta 3 integrin in mediating fibrin gel retraction. J Biol Chem 270, 1785, 1995.
34. Ikari, Y., Yee, K.O., and Schwartz, S.M. Role of alpha5beta1 and alphavbeta3 integrins on smooth muscle cell spreading and migration in fibrin gels. Thromb Haemost 84, 701, 2000.
35. Riopel, M., Stuart, W., and Wang, R. Fibrin improves beta (INS-1) cell function, proliferation and survival through integrin alphavbeta3. Acta Biomater 9, 8140, 2013.
36. Podolnikova, N.P., Yakovlev, S., Yakubenko, V.P., Wang, X., Gorkun, O.V., and Ugarova, T.P. The interaction of integrin alphaIIb beta3 with fibrin occurs through multiple binding sites in the alphaIIb beta-propeller domain. J Biol Chem 289, 2371, 2014.
37. Gorlatov, S., and Medved, L. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. Biochemistry 41, 4107, 2002.
38. Sahni, A., and Francis, C.W. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96, 3772, 2000.
39. Altieri, D.C., Bader, R., Mannucci, P.M., and Edgington, T.S. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol 107, 1893, 1988.
40. Ahmed, T.A., Dare, E.V., and Hincke, M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 14, 199, 2008.
41. Hoffman, A.S. Hydrogels for biomedical applications. Adv Drug Deliv Rev 54, 3, 2002.
42. Lee, C.R., Grad, S., Gorna, K., Gogolewski, S., Goessl, A., and Alini, M. Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng 11, 1562, 2005.
43. Van Lieshout, M., Peters, G., Rutten, M., and Baaijens, F. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng 12, 481, 2006.
44. Weinand, C., Gupta, R., Huang, A.Y., Weinberg, E., Madisch, I., Qudsi, R.A., et al. Comparison of hydrogels in the in vivo formation of tissue-engineered bone using mesenchymal stem cells and beta-tricalcium phosphate. Tissue Eng 13, 757, 2007.
45. Haugh, M.G., Thorpe, S.D., Vinardell, T., Buckley, C.T., and Kelly, D.J. The application of plastic compression to modulate fibrin hydrogel mechanical properties. J Mech Behav Biomed Mater 16, 66, 2012.
46. Helms, C.C., Ariens, R.A., Uitte de Willige, S., Standeven, K.F., and Guthold, M. Alpha-alpha cross-links increase fibrin fiber elasticity and stiffness. Biophys J 102, 168, 2012.
47. Marx, G. Evolution of fibrin glue applicators. Transfus Med Rev 17, 287, 2003.
48. Spotnitz, W.D. Fibrin sealant: past, present, and future: a brief review. World J Surg 34, 632, 2010.
49. Caiado, F., Carvalho, T., Silva, F., Castro, C., Clode, N., Dye, J.F., et al. The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healing. Biomaterials 32, 7096, 2011.
50. Gorodetsky, R., Clark, R.A., An, J., Gailit, J., Levdansky, L., Vexler, A., et al. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. J Invest Dermatol 112, 866, 1999.
51. Horch, R.E., Bannasch, H., and Stark, G.B. Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. Transplant Proc 33, 642, 2001.
52. Naik, B., Karunakar, P., Jayadev, M., and Marshal, V.R. Role of Platelet rich fibrin in wound healing: a critical review. J Conserv Dent 16, 284, 2013.
53. Dohan Ehrenfest, D.M., Del Corso, M., Diss, A., Mouhyi, J., and Charrier, J.B. Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol 81, 546, 2010.
54. Choukroun, J., Diss, A., Simonpieri, A., Girard, M.O., Schoeffler, C., Dohan, S.L., et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101, e56, 2006.
55. Simonpieri, A., Choukroun, J., Del Corso, M., Sammartino, G., and Dohan Ehrenfest, D.M. Simultaneous sinuslift and implantation using microthreaded implants and leukocyte- and platelet-rich fibrin as sole grafting material: a six-year experience. Implant Dent 20, 2, 2011.
56. Anilkumar, K., Geetha, A., Umasudhakar, Ramakrishnan, T., Vijayalakshmi, R., and Pameela, E. Platelet-rich-fibrin: a novel root coverage approach. J Indian Soc Periodontol 13, 50, 2009.
57. Gassling, V., Hedderich, J., Acil, Y., Purcz, N., Wiltfang, J., and Douglas, T. Comparison of platelet rich fibrin and collagen as osteoblast-seeded scaffolds for bone tissue engineering applications. Clin Oral Implants Res 24, 320, 2013.
58. Cieslik-Bielecka, A., Choukroun, J., Odin, G., and Dohan Ehrenfest, D.M. L-PRP/L-PRF in esthetic plastic surgery, regenerative medicine of the skin and chronic wounds. Curr Pharm Biotechnol 13, 1266, 2012.
59. Kim, J., Rubin, N., Huang, Y., Tuan, T.L., and Lien, C.L. In vitro culture of epicardial cells from adult zebrafish heart on a fibrin matrix. Nat Protoc 7, 247, 2012.
60. Ye, Q., Zund, G., Benedikt, P., Jockenhoevel, S., Hoerstrup, S.P., Sakyama, S., et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17, 587, 2000.
61. Mol, A., van Lieshout, M.I., Dam-de Veen, C.G., Neuenschwander, S., Hoerstrup, S.P., Baaijens, F.P., et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26, 3113, 2005.
62. Xiong, A., Austin, T.W., Lagasse, E., Uchida, N., Tamaki, S., Bordier, B.B., et al. Isolation of human fetal liver progenitors and their enhanced proliferation by threedimensional coculture with endothelial cells. Tissue Eng Part A 14, 995, 2008.
63. Marx, G., Mou, X., Hotovely-Salomon, A., Levdansky, L., Gaberman, E., Belenky, D., et al. Heat denaturation of fibrinogen to develop a biomedical matrix. J Biomed Mater Res B Appl Biomater 84, 49, 2008.
64. Kassis, I., Zangi, L., Rivkin, R., Levdansky, L., Samuel, S., Marx, G., et al. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant 37, 967, 2006.
65. Ben-Ari, A., Rivkin, R., Frishman, M., Gaberman, E., Levdansky, L., and Gorodetsky, R. Isolation and implantation of bone marrow-derived mesenchymal stem cells with fibrin micro beads to repair a critical-size bone defect in mice. Tissue Eng Part A 15, 2537, 2009.
66. Rivkin, R., Ben-Ari, A., Kassis, I., Zangi, L., Gaberman, E., Levdansky, L., et al. High-yield isolation, expansion, and differentiation of murine bone marrow-derived mesenchymal stem cells using fibrin microbeads (FMB). Cloning Stem Cells 9, 157, 2007.
67. Gurevich, O., Vexler, A., Marx, G., Prigozhina, T., Levdansky, L., Slavin, S., et al. Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. Tissue Eng 8, 661, 2002.
68. Zhou, H., and Xu, H.H. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials 32, 7503, 2011.
69. Colley, H., McArthur, S.L., Stolzing, A., and Scutt, A. Culture on fibrin matrices maintains the colony-forming capacity and osteoblastic differentiation of mesenchymal stem cells. Biomed Mater 7, 045015, 2012.
70. Pelaez, D., Huang, C.Y., and Cheung, H.S. Cyclic compression maintains viability and induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds. Stem Cells Dev 18, 93, 2009.
71. Haleem, A.M., Singergy, A.A., Sabry, D., Atta, H.M., Rashed, L.A., Chu, C.R., et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 1, 253, 2010.
72. Ahmed, T.A., Giulivi, A., Griffith, M., and Hincke, M. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng Part A 17, 323, 2011.
73. Willerth, S.M., Arendas, K.J., Gottlieb, D.I., and Sakiya-ma-Elbert, S.E. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 27, 5990, 2006.
74. Willerth, S.M., Faxel, T.E., Gottlieb, D.I., and Sakiyama-Elbert, S.E. The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells 25, 2235, 2007.
75. Mooney, R., Tawil, B., and Mahoney, M. Specific fibrinogen and thrombin concentrations promote neuronal rather than glial growth when primary neural cells are seeded within plasma-derived fibrin gels. Tissue Eng Part A 16, 1607, 2010.
76. Schense, J.C., and Hubbell, J.A. Three-dimensional migration of neurites is mediated by adhesion site density and affinity. J Biol Chem 275, 6813, 2000.
77. Sakiyama, S.E., Schense, J.C., and Hubbell, J.A. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J 13, 2214, 1999.
78. Man, A.J., Davis, H.E., Itoh, A., Leach, J.K., and Bannerman, P. Neurite outgrowth in fibrin gels is regulated by substrate stiffness. Tissue Eng Part A 17, 2931, 2011.
79. Ju, Y.E., Janmey, P.A., McCormick, M.E., Sawyer, E.S., and Flanagan, L.A. Enhanced neurite growth from mammalian neurons in three-dimensional salmon fibrin gels. Biomaterials 28, 2097, 2007.
80. Navaei-Nigjeh, M., Amoabedini, G., Noroozi, A., Azami, M., Asmani, M.N., Ebrahimi-Barough, S., et al. Enhancing neuronal growth from human endometrial stem cells derived neuron-like cells in three-dimensional fibrin gel for nerve tissue engineering. J Biomed Mater Res A 102, 2533, 2014.
81. Herbert, C.B., Bittner, G.D., and Hubbell, J.A. Effects of fibinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels. J Comp Neurol 365, 380, 1996.
82. Chalupowicz, D.G., Chowdhury, Z.A., Bach, T.L., Barsigian, C., and Martinez, J. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 130, 207, 1995.
83. van Hinsbergh, V.W., Koolwijk, P., and Hanemaaijer, R. Role of fibrin and plasminogen activators in repairassociated angiogenesis: in vitro studies with human endothelial cells. EXS 79, 391, 1997.
84. Feng, X., Tonnesen, M.G., Mousa, S.A., and Clark, R.A. Fibrin and collagen differentially but synergistically regulate sprout angiogenesis of human dermal microvascular endothelial cells in 3-dimensional matrix. Int J Cell Biol 2013, 231279, 2013.
85. Holnthoner, W., Hohenegger, K., Husa, A.M., Muehleder, S., Meinl, A., Peterbauer-Scherb, A., et al. Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix. J Tissue Eng Regen Med 2012. DOI: 10.1002/term.1620.
86. Barsotti, M.C., Magera, A., Armani, C., Chiellini, F., Felice, F., Dinucci, D., et al. Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif 44, 33, 2011.
87. Sukmana, I., and Djuansjah, J.R.P. Sandwiched polymer fibre in fibrin matrices for the dictation of endothelial cells undergoing angiogenesis. J Phys Conf Ser 423, 2019, 2013.
88. Hadjizadeh, A., and Doillon, C.J. Directional migration of endothelial cells towards angiogenesis using polymer fibres in a 3D co-culture system. J Tissue Eng Regen Med 4, 524, 2010.
89. Strassburg, S., Nienhueser, H., Bjorn Stark, G., Finkenzeller, G., and Torio-Padron, N. Co-culture of adiposederived stem cells and endothelial cells in fibrin induces angiogenesis and vasculogenesis in a chorioallantoic membrane model. J Tissue Eng Regen Med 2013. DOI: 10.1002/term.1769.
90. Blumenthal, J., Cohen-Matsliah, S.I., and Levenberg, S. Olfactory bulb-derived cells seeded on 3D scaffolds exhibit neurotrophic factor expression and pro-angiogenic properties. Tissue Eng Part A 19, 2284, 2013.
91. Kachgal, S., Carrion, B., Janson, I.A., and Putnam, A.J. Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. J Cell Physiol 227, 3546, 2012.
92. Ucuzian, A.A., Bufalino, D.V., Pang, Y., and Greisler, H.P. Angiogenic endothelial cell invasion into fibrin is stimulated by proliferating smooth muscle cells. Microvasc Res 90, 40, 2013.
93. Chen, Z., Htay, A., Dos Santos, W., Gillies, G.T., Fillmore, H.L., Sholley, M.M., et al. In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells. J Neurooncol 92, 121, 2009.
94. Roy, S., Driggs, J., Elgharably, H., Biswas, S., Findley, M., Khanna, S., et al. Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wound Repair Regen 19, 753, 2011.
95. Birla, R.K., Borschel, G.H., Dennis, R.G., and Brown, D.L. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng 11, 803, 2005.
96. Flanagan, T.C., Sachweh, J.S., Frese, J., Schnoring, H., Gronloh, N., Koch, S., et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 15, 2965, 2009.
97. Weber, M., Heta, E., Moreira, R., Gesche, V.N., Schermer, T., Frese, J., et al. Tissue-engineered fibrin-based heart valve with a tubular leaflet design. Tissue Eng Part C Methods 20, 265, 2014.
98. Jockenhoevel, S., Chalabi, K., Sachweh, J.S., Groesdonk, H.V., Demircan, L., Grossmann, M., et al. Tissue engineering: complete autologous valve conduit-a new moulding technique. Thorac Cardiovasc Surg 49, 287, 2001.
99. Kaminski, A., Klopsch, C., Mark, P., Yerebakan, C., Donndorf, P., Gabel, R., et al. Autologous valve replacement CD133 + stem cell plus fibrin composite-based sprayed cell seeding for intraoperative heart valve tissue engineering. Tissue Eng Pt C-Meth 17, 299, 2011.
100. Bruns, H., Kneser, U., Holzhuter, S., Roth, B., Kluth, J., Kaufmann, P.M., et al. Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng 11, 1718, 2005.
101. Fiegel, H.C., Pryymachuk, G., Rath, S., Bleiziffer, O., Beier, J.P., Bruns, H., et al. Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat. J Cell Mol Med 14, 267, 2010.
102. Sun, T., Chan, M.L., Quek, C.H., and Yu, H. Improving mechanical stability and density distribution of hepatocyte microcapsules by fibrin clot and gold nano-particles. J Biotechnol 111, 169, 2004.
103. Yamada, Y., Boo, J.S., Ozawa, R., Nagasaka, T., Okazaki, Y., Hata, K., et al. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J Craniomaxillofac Surg 31, 27, 2003.
104. Falanga, V., Iwamoto, S., Chartier, M., Yufit, T., Butmarc, J., Kouttab, N., et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13, 1299, 2007.
105. Johnson, P.J., Tatara, A., McCreedy, D.A., Shiu, A., and Sakiyama-Elbert, S.E. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 6, 5127, 2010.
106. Lee, A.C., Yu, V.M., Lowe, J.B., 3rd, Brenner, M.J., Hunter, D.A., Mackinnon, S.E., et al. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol 184, 295, 2003.
107. Taylor, S.J., McDonald, J.W., 3rd, and Sakiyama-Elbert, S.E. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release 98, 281, 2004.
108. McGrath, A.M., Brohlin, M., Kingham, P.J., Novikov, L.N., Wiberg, M., and Novikova, L.N. Fibrin conduit supplemented with human mesenchymal stem cells and immunosuppressive treatment enhances regeneration after peripheral nerve injury. Neurosci Lett 516, 171, 2012.
109. Carriel, V., Garrido-Gomez, J., Hernandez-Cortes, P., Garzon, I., Garcia-Garcia, S., Saez-Moreno, J.A., et al. Combination of fibrin-agarose hydrogels and adiposederived mesenchymal stem cells for peripheral nerve regeneration. J Neural Eng 10, 026022, 2013.
110. King, V.R., Alovskaya, A., Wei, D.Y., Brown, R.A., and Priestley, J.V. The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury. Biomaterials 31, 4447, 2010.
111. Ciano, P.S., Colvin, R.B., Dvorak, A.M., McDonagh, J., and Dvorak, H.F. Macrophage migration in fibrin gel matrices. Lab Invest 54, 62, 1986.
112. Szaba, F.M., and Smiley, S.T. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99, 1053, 2002.
113. Nadeau, K.C., Azuma, H., and Tilney, N.L. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci U S A 92, 8729, 1995.
114. Cole, D.R., Waterfall, M., McIntyre, M., and Baird, J.D. Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. Diabetologia 35, 231, 1992.
115. Yi, T., and Song, S.U. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res 35, 213, 2012.
116. Gibly, R.F., Graham, J.G., Luo, X., Lowe, W.L., Jr., Hering, B.J., and Shea, L.D. Advancing islet transplantation: from engraftment to the immune response. Diabetologia 54, 2494, 2011.
117. Shaw, J.E., Sicree, R.A., and Zimmet, P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4, 2010.
118. Cramer, J.A., and Pugh, M.J. The influence of insulin use on glycemic control: How well do adults follow prescriptions for insulin? Diabetes Care 28, 78, 2005.
119. Beattie, G.M., Montgomery, A.M., Lopez, A.D., Hao, E., Perez, B., Just, M.L., et al. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 51, 3435, 2002.
120. Sabra, G., and Vermette, P. A 3D cell culture system: separation distance between INS-1 cell and endothelial cell monolayers co-cultured in fibrin influences INS-1 cells insulin secretion. Biotechnol Bioeng 110, 619, 2013.
121. Kuehn, C., Lakey, J.R., Lamb, M.W., and Vermette, P. Young porcine endocrine pancreatic islets cultured in fibrin show improved resistance toward hydrogen peroxide. Islets 5, 207, 2013.
122. Riopel, M., Krishnamurthy, M., Li, J., Liu, S., Leask, A., and Wang, R. Conditional beta1-integrin-deficient mice display impaired pancreatic beta cell function. J Pathol 224, 45, 2011.
123. Diaferia, G.R., Jimenez-Caliani, A.J., Ranjitkar, P., Yang, W., Hardiman, G., Rhodes, C.J., et al. beta1 integrin is a crucial regulator of pancreatic beta-cell expansion. Development 140, 3360, 2013.
124. Saleem, S., Li, J., Yee, S.P., Fellows, G.F., Goodyer, C.G., and Wang, R. beta1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival. J Pathol 219, 182, 2009.
125. Krishnamurthy, M., Li, J., Fellows, G.F., Rosenberg, L., Goodyer, C.G., and Wang, R. Integrin {alpha}3, but not {beta}1, regulates islet cell survival and function via PI3K/ Akt signaling pathways. Endocrinology 152, 424, 2011.
126. Linn, T., Schneider, K., Hammes, H.P., Preissner, K.T., Brandhorst, H., Morgenstern, E., et al. Angiogenic capacity of endothelial cells in islets of Langerhans. FASEB J 17, 881, 2003.
127. Mason, M.N., and Mahoney, M.J. A novel composite construct increases the vascularization potential of PEG hydrogels through the incorporation of large fibrin ribbons. J Biomed Mater Res A 95, 283, 2010.
128. Maillard, E., Juszczak, M.T., Clark, A., Hughes, S.J., Gray, D.R., and Johnson, P.R. Perfluorodecalin-enriched fibrin matrix for human islet culture. Biomaterials 32, 9282, 2011.
129. Wechselberger, G., Russell, R.C., Neumeister, M.W., Schoeller, T., Piza-Katzer, H., and Rainer, C. Successful transplantation of three tissue-engineered cell types using capsule induction technique and fibrin glue as a delivery vehicle. Plast Reconstr Surg 110, 123, 2002.
130. Kim, J.S., Lim, J.H., Nam, H.Y., Lim, H.J., Shin, J.S., Shin, J.Y., et al. In situ application of hydrogel-type fi-brin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation. J Control Release 162, 382, 2012.
131. Nyqvist, D., Kohler, M., Wahlstedt, H., and Berggren, P.O. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 54, 2287, 2005.
132. van Deijnen, J.H., Hulstaert, C.E., Wolters, G.H., and van Schilfgaarde, R. Significance of the peri-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig, and man. Cell Tissue Res 267, 139, 1992.
133. Brissova, M., Fowler, M., Wiebe, P., Shostak, A., Shiota, M., Radhika, A., et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 53, 1318, 2004.
134. Sabek, O., Gaber, M.W., Wilson, C.M., Zawaski, J.A., Fraga, D.W., and Gaber, O. Imaging of human islet vascularization using a dorsal window model. Transplant Proc 42, 2112, 2010.
135. Pepper, A.R., Gala-Lopez, B., Ziff, O., and Shapiro, A.M. Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol 2013, 352315, 2013.
136. Lim, J.Y., Min, B.H., Kim, B.G., Han, H.J., Kim, S.J., Kim, C.W., et al. A fibrin gel carrier system for islet transplantation into kidney subcapsule. Acta Diabetol 46, 243, 2009.
137. Andrades, P., Asiedu, C., Rodriguez, C., Goodwin, K.J., McCarn, J., and Thomas, J.M. Subcutaneous pancreatic islet transplantation using fibrin glue as a carrier. Transplant Proc 39, 191, 2007.
138. Kayali, A.G., Flores, L.E., Lopez, A.D., Kutlu, B., Baetge, E., Kitamura, R., et al. Limited capacity of human adult islets expanded in vitro to redifferentiate into insulinproducing beta-cells. Diabetes 56, 703, 2007.
139. O'Sullivan, E.S., Vegas, A., Anderson, D.G., and Weir, G.C. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev 32, 827, 2011.
140. de Vos, P., Hamel, A.F., and Tatarkiewicz, K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45, 159, 2002.
141. Malaisse, W.J., Olivares, E., Belcourt, A., and Nilsson, K. Immobilization of pancreatic islet cells with preserved secretory potential. Appl Microbiol Biotechnol 52, 652, 1999.
142. Silva, A.I., de Matos, A.N., Brons, I.G., and Mateus, M. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus. Med Res Rev 26, 181, 2006.
143. Colom, A., Galgoczy, R., Almendros, I., Xaubet, A., Farre, R., and Alcaraz, J. Oxygen diffusion and consumption in extracellular matrix gels: implications for designing three-dimensional cultures. J Biomed Mater Res A 102, 2776, 2014.
144. Hentze, H., Soong, P.L., Wang, S.T., Phillips, B.W., Putti, T.C., and Dunn, N.R. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2, 198, 2009.
145. Fumimoto, Y., Matsuyama, A., Komoda, H., Okura, H., Lee, C.M., Nagao, A., et al. Creation of a rich subcutaneous vascular network with implanted adipose tissue-derived stromal cells and adipose tissue enhances subcutaneous grafting of islets in diabetic mice. Tissue Eng Part C Methods 15, 437, 2009.
146. Sigrist, S., Mechine-Neuville, A., Mandes, K., Calenda, V., Braun, S., Legeay, G., et al. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant 12, 627, 2003.